In partnership with:
This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants
Nicole S. Delino, Manabu Aoki, Hironori Hayashi, Shin-ichiro Hattori, Simon B. Chang, Yuki Takamatsu, Cuthbert D. Martyr, Debananda Das, Arun K. Ghosh, Hiroaki Mitsuya- Antimicrobial Agents and Chemotherapy, February 2018, ASM Journals
- DOI: 10.1128/aac.02060-17